HF1029

Heritable or congenital disorder revision of lists of tests required to be administered for determination of presence.
Legislative Session 94 (2025-2026)

Related bill: SF1494

AI Generated Summary

The legislative bill H.F. No. 1029 is aimed at revising and updating the list of medical tests required to detect heritable or congenital disorders in Minnesota. This bill mandates the Commissioner of Health to periodically update this list, incorporating new medical advancements and testing methods that can improve public health outcomes. The decisions on which tests to administer will consider several factors, including the reliability of the test, the treatability of the disorder, and the severity of the health conditions that could arise from the disorders.

Specific changes proposed by the bill include: - Empowering the commissioner to periodically update the testing list as medical science progresses. - Any updates to the testing list need advisory committee recommendations, commissioner's approval, and publication in the State Register. - The bill simplifies the process by exempting these revisions from the usual rulemaking procedures found in chapter 14 of Minnesota statutes.

The bill also specifically adds testing for metachromatic leukodystrophy (MLD) to the list of mandatory screenings.

Overall, the bill is intended to keep Minnesota's health screenings for heritable and congenital disorders in line with the latest medical practices and to ensure timely updates without undergoing the standard, more lengthy rulemaking processes.

Bill text versions

Showing the most recent version. There are  2  total versions. You must be logged in  to view additional bill text versions.

Actions

DateChamberWhereTypeNameCommittee Name
February 17, 2025HouseActionIntroduction and first reading, referred toHealth Finance and Policy
February 19, 2025HouseActionAuthors added
February 24, 2025HouseActionAuthor added
March 26, 2025HouseActionAuthor added
Showing the 5  most recent stages. This bill has 4  stages in total. Log in to view all stages

Citations

You must be logged in  to view citations.

Progress through the legislative process

17%
In Committee

Sponsors

You must be logged in  to view sponsors.

Loading…